The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity
- PMID: 26909323
- PMCID: PMC4732191
- DOI: 10.1016/j.nicl.2015.08.009
The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity
Abstract
Stimulation of serotonergic neurotransmission by psilocybin has been shown to shift emotional biases away from negative towards positive stimuli. We have recently shown that reduced amygdala activity during threat processing might underlie psilocybin's effect on emotional processing. However, it is still not known whether psilocybin modulates bottom-up or top-down connectivity within the visual-limbic-prefrontal network underlying threat processing. We therefore analyzed our previous fMRI data using dynamic causal modeling and used Bayesian model selection to infer how psilocybin modulated effective connectivity within the visual-limbic-prefrontal network during threat processing. First, both placebo and psilocybin data were best explained by a model in which threat affect modulated bidirectional connections between the primary visual cortex, amygdala, and lateral prefrontal cortex. Second, psilocybin decreased the threat-induced modulation of top-down connectivity from the amygdala to primary visual cortex, speaking to a neural mechanism that might underlie putative shifts towards positive affect states after psilocybin administration. These findings may have important implications for the treatment of mood and anxiety disorders.
Keywords: Depression; Dynamic causal modeling; Psilocybin; Serotonin; fMRI.
Figures
Similar articles
-
Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.Eur Neuropsychopharmacol. 2018 Jun;28(6):691-700. doi: 10.1016/j.euroneuro.2018.03.016. Epub 2018 Apr 25. Eur Neuropsychopharmacol. 2018. PMID: 29703645
-
Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.Cereb Cortex. 2014 Dec;24(12):3221-31. doi: 10.1093/cercor/bht178. Epub 2013 Jul 16. Cereb Cortex. 2014. PMID: 23861318 Clinical Trial.
-
Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.J Psychopharmacol. 2020 Feb;34(2):167-180. doi: 10.1177/0269881119895520. Epub 2020 Jan 16. J Psychopharmacol. 2020. PMID: 31941394 Clinical Trial.
-
Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.J Psychoactive Drugs. 2024 Jul-Aug;56(3):301-315. doi: 10.1080/02791072.2023.2223195. Epub 2023 Jun 29. J Psychoactive Drugs. 2024. PMID: 37385217 Review.
-
Psilocybin for treating substance use disorders?Expert Rev Neurother. 2017 Feb;17(2):203-212. doi: 10.1080/14737175.2016.1220834. Epub 2016 Aug 12. Expert Rev Neurother. 2017. PMID: 27684102 Review.
Cited by
-
Sex-specific effects of psychedelic drug exposure on central amygdala reactivity and behavioral responding.Transl Psychiatry. 2023 Apr 8;13(1):119. doi: 10.1038/s41398-023-02414-5. Transl Psychiatry. 2023. PMID: 37031219 Free PMC article.
-
Mini-review: The neurobiology of treating substance use disorders with classical psychedelics.Front Neurosci. 2023 Apr 17;17:1156319. doi: 10.3389/fnins.2023.1156319. eCollection 2023. Front Neurosci. 2023. PMID: 37139521 Free PMC article. Review.
-
Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca.J Psychopharmacol. 2022 Mar;36(3):295-308. doi: 10.1177/02698811221080165. J Psychopharmacol. 2022. PMID: 35253514 Free PMC article.
-
The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies.Front Pharmacol. 2021 Sep 29;12:739053. doi: 10.3389/fphar.2021.739053. eCollection 2021. Front Pharmacol. 2021. PMID: 34658876 Free PMC article. Review.
-
Psychedelics, Sociality, and Human Evolution.Front Psychol. 2021 Sep 29;12:729425. doi: 10.3389/fpsyg.2021.729425. eCollection 2021. Front Psychol. 2021. PMID: 34659037 Free PMC article.
References
-
- First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., Benjamin L.S. American Psychiatric Press, Inc.; Washington, D.C.: 1997. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II)
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
